2076975 2077203
최종편집 2024-03-28 17:56 (목)
Target price of Korean leading pharmaceutical companies drops after the 2Q earnings report
상태바
Target price of Korean leading pharmaceutical companies drops after the 2Q earnings report
  • Hyeokgi Lee, Newsmp
  • 승인 2021.08.23 17:00
  • 댓글 0
이 기사를 공유합니다

Securities firms lower the price target through analysis report… only Daewoong Pharmaceutical rises

Major top pharmaceutical companies left improved performance in the second quarter, but the securities firms lowered their target stock prices.

Most of the top pharmaceutical companies have announced preliminary operating income since the end of July.

While the earning announcements of leading pharmaceutical companies have been completed, the BIG 5 recovered the average growth from 3.7% in 1Q to 9.1% in 2Q,

Nevertheless, major securities firms have lowered their target prices.

Among them, KIWOOM Securities revised the target price from 99,000 to 90,000 won on July 30th for Yuhan Corp., the first to disclose preliminary earnings on the 29th.

On August 2nd, KTB Investment & Securities lowered GC Pharma’s price target by 22.0%, from 590,000 to 460,000 won.

KTB Investment & Securities also lowered Chong Kun Dang Pharmaceutical’s target price by 10.5% from 190,000 to 170,000 won on the same day, while KIWOOM Securities also dropped its price target from 160,000 to 150,000 won.

On the 9th, Shinhan Investment, Daishin Securities, Yuanta Securities, and DB Financial Investment also cut the target price of Hanmi Pharmaceutical.

Yuanta Securities lowered 7.0% from 430,000 to 400,000 won, DaiShin Securities 5.1% from 390,000 to 370,000 won, DB Financial Investment 2.6% from 390,000 to 380,000 won, and Shinhan Investment 2.6% from 380,000 to 370,000 won.

Following BIG 5, Samsung Securities revised Dong-A ST’s target price from 110,000 to 100,000 won on the 11th after Dong-A ST announced its preliminary earnings report.

On the other hand, only Daewoong Pharmaceutical received positive reviews among BIG5 pharmaceutical companies. On the 30thj of last month, Shinyoung Securities raised its target price from 200,000 to 220,000 won, and Yuanta Securities by 17.6% from 170,000 to 200,000 won.


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.